Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases. The company announced preclinical test results that showed Telomir-1 prevented cellular aging in human progeria cell lines. This is further evidence that Telomir-1 has the potential to be a game-changing treatment in diseases associated with aging.
